Explanation
Dactatasvir andsofosbuvir
Daclatasvirisuicensedforuseincombination withsofosbuvirforthe
treatmentofchronichepatitisCinfectionof qenotvpeslor 4. wth or
withoutcompensatedcirrhosis.Theadditionof ribavirin shouldbe
consideredfor oatientswith advancedlverdiseaseor with other
negativeproanosticfactors. such as prior treatmentexperience.
Daclatasviris anNS5A inhibitor which stops hepatitis C viral
replication.andincombination withsofosbuvirisassociated withmuch
hiaherviraLresponse rates thantraditionat optionsfortreatinq
hepatitisC.
@1MIN ENDOCRINE
